Hospital formulary Journal Impact Factor & Information

Current impact factor: 0.00

Impact Factor Rankings

2015 Impact Factor Available summer 2016
1997 Impact Factor 0.294

Additional details

5-year impact 0.00
Cited half-life 0.00
Immediacy index 0.00
Eigenfactor 0.00
Article influence 0.00
Other titles Hospital formulary
ISSN 0098-6909
OCLC 1512185
Material type Periodical, Internet resource
Document type Journal / Magazine / Newspaper, Internet Resource

Publications in this journal

  • [Show abstract] [Hide abstract]
    ABSTRACT: This study compares the cost-effectiveness of the 4 most common empiric antimicrobial regimens used for the treatment of adults with community-acquired pneumonia (CAP) at a community health system during a 6-month period. Associations between initial antimicrobials and total hospital costs were determined. Cost-effectiveness ratios were determined by dividing the total hospital costs by the percent survival. A total of 415 patients met criteria for the Pneumonia Severity Index (PSI) risk class IV or V. Costs (adjusted for inflation) were as follows (median, 25th and 75th percentile): total hospital costs ($5,078 [$3,218-$8,144]), pharmacy costs ($753 [$455-$1,357]), and antibiotic costs ($139 [$82-$229]). The most favorable cost-effectiveness ratio was observed for patients who received levofloxacin monotherapy ($4,635 per life saved), followed by ceftriaxone plus a macrolide ($5,278), ceftriaxone monotherapy ($5,368), and ceftriaxone plus levofloxacin ($6,317). Among patients admitted to the medical floor for class IV or V CAP, empiric levofloxacin monotherapy was associated with greater cost-effectiveness than ceftriaxone monotherapy, ceftriaxone plus a macrolide, or ceftriaxone plus levofloxacin.
    Hospital formulary 09/2005; 40(9):298-303.
  • [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate the effectivenenss of interventions to improve oral antihypertensive drug adherence, we conducted a quantitative review of trials that tested one or more intervention strategies and included drug adherence as a study endpoint. A Medline search and bibliography review of published articles yielded 29 trials meeting inclusion criteria. Statistically significant improvements in adherence were observed in single-blind trials of worksite care, physician education, and an electronic vial cap, and in unblinded trials of patient cards and calendar packaging. There was insufficient evidence to support the effectiveness of mailed reminders alone, according to unblinded trials. Adherence results were conflicting for patient education and inconclusive for patient counseling. Self-monitoring was deemed ineffective according to single-blind trials. Results for meeting goal diastolic blood pressure, when evaluated (if available), were generally in accordance with those for adherence.
    Hospital formulary 03/2000; 35(3):234-255.
  • B Gatty ·

    Hospital formulary 05/1995; 30(4):238, 237.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The Veterans Administration Lakeside Medical Center (VALMC) is a 500-bed hospital located in downtown Chicago providing a broad scope of inpatient and outpatient medical services for more than 12,000 veterans. The VALMC Pharmacy and Therapeutics Committee requested a study to evaluate doxazosin mesylate (Cardura) to determine if this agent would be an acceptable alternative to other formulary agents. It appears that doxazosin provides several therapeutic advantages, including once-daily dosing, when compared with other more costly antihypertensive agents.
    Hospital formulary 05/1995; 30(4):233-6.
  • [Show abstract] [Hide abstract]
    ABSTRACT: A retrospective adverse drug reaction (ADR) reporting system has been in place at Cedars-Sinai Medical Center for 7 years. Initially, the system identified 300 to 400 ADRs per year. After adding a checklist, that number increased to 750 to 850 per year, an ADR rate of about 2% of total patient admissions. To increase the ADR reporting rate, we initiated a concurrent surveillance program in conjunction with the retrospective system. In the first year of the program, the combined systems identified 1,174 ADRs. In addition, the ADR rate per 100 patient days increased to between 0.5 and 0.7, and the ADR per admission rate increased to 4%. As a result of the more effective ADR surveillance program, the P & T Committee has additional data from which to develop guidelines and educational programs to increase ADR awareness and prevention, and thus, to improve patient outcomes.
    Hospital formulary 04/1995; 30(4):226-8, 231-2.

  • Hospital formulary 04/1995; 30(3):171-2.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Although UCLA had established policies and procedures for visiting pharmaceutical representatives, changes in both the pharmaceutical business environment and in UCLA's physical environment mandated an update. To deal with the changes, a multidisciplinary team comprised of various departmental staff members met to develop a new vendor representative visitation policy that included the practice of drug sample distribution. More stringent registration requirements and shared responsibility for policy enforcement are the key elements of the new policy.
    Hospital formulary 04/1995; 30(3):161-5; discussion 163-9.
  • B Gatty ·

    Hospital formulary 04/1995; 30(3):178, 177.
  • [Show abstract] [Hide abstract]
    ABSTRACT: To assess the long-term impact of a therapeutic interchange program on the use of target antimicrobial drugs, we conducted a retrospective study of target drug utilization at our institution--a 1,000-bed Canadian tertiary care teaching hospital. Data were assessed to determine target drug utilization, incidence of therapeutic interchanges, and patient-target drug exposures. Results showed that the incidence of therapeutic interchanges per patient-target drug exposure decreased from a mean of 23% to 2%, resulting in a total net savings for the target drugs of approximately $1.07 million (Canadian) over 6 years. Prescriber acceptance and low manpower requirements combine to make this a useful method of altering prescribing patterns and reducing drug and drug delivery costs.
    Hospital formulary 03/1995; 30(2):92-3, 97-8, 100 passim.
  • B Gatty ·

    Hospital formulary 03/1995; 30(2):118, 117.
  • [Show abstract] [Hide abstract]
    ABSTRACT: A computerized medication system, implemented at Rochester (MN) Methodist Hospital in 1987, has been adopted by the hospitals at the Mayo Medical Center, Rochester, MN. A key component of the medication system, which uses individualized patient medication envelopes, is the delivery of doses of medications to nursing units just before their administration time. The system has been shown to provide greater nursing support, increase patient safety by reducing medication errors, and decrease both full-time equivalent costs and operating costs. The immediate impact of the system has been to shift dose scheduling from a nursing to a pharmacy responsibility. At Duke University, an automated pharmacy system (APS) has been in operation since October 1993 and is used to dispense the majority of unit dose drugs. The APS provides up-to-the-minute information about the drugs that patients are receiving, which is used to fill each patient's unit dose drawer. It has not dispensed an incorrect drug since its installation and has allowed centralization of the unit dose cart system. Other benefits include decreased billing labor and increased drug usage reporting.
    Hospital formulary 03/1995; 30(2):106-13.
  • A Bakst ·
    [Show abstract] [Hide abstract]
    ABSTRACT: What is pharmacoeconomics and why is there growing interest in this concept by those who work in or serve the medical community? This article provides a brief explanation of this concept and its importance from an institutional perspective. Additionally, the tasks typically associated with the position of a pharmacoeconomist in the hospital setting are defined. Also described are the types of cost analyses that can be used, the relationship between pharmaceutical care and pharmacoeconomics, and finally, two examples of how pharmacoeconomic principles are actually being used in the formulary decision-making process at a major tertiary care center--The Cleveland Clinic Foundation.
    Hospital formulary 02/1995; 30(1):42-50.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The P & T Committee of our institution, a 285-bed, non-tertiary care regional medical center, undertook a study to evaluate the use of the aminoglycoside amikacin sulfate (Amikin). Results of an initial DUE, a follow-up to an educational effort, and the estimated annual cost savings that could be achieved with appropriate prescribing of aminoglycosides are presented.
    Hospital formulary 02/1995; 30(2):114-6.
  • B Gatty ·

    Hospital formulary 02/1995; 30(1):58, 57.
  • [Show abstract] [Hide abstract]
    ABSTRACT: What strategies are effective for educating your medical staff about medications and medication-related issues? Kaiser Permanente of Ohio has developed an educational program for its medical staff that involves four key components: a custom-designed formulary handbook, drug fairs, traditional letter/newsletter communication pieces and educational meetings, and collaborative projects between its pharmacy and medical staffs. These educational techniques--many of which have been successfully adapted from the pharmaceutical industry--can be adopted for use at your institution.
    Hospital formulary 01/1995; 29(12):828-32; discussion 833-5.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The goal of our program was to implement an easily maintained system that could document, classify, and determine the economic significance of clinical pharmacy interventions on a medicine division of an 874-bed university teaching hospital. This clinical intervention documentation system, which emphasizing both quality of care issues and pharmacist productivity, can be easily implemented by other institutions.
    Hospital formulary 12/1994; 29(11):773, 777-9.
  • B Gatty ·

    Hospital formulary 12/1994; 29(11):786, 785.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Empowering pharmacists to have direct control and responsibility for institutional drug-use protocols can assist in reducing costs and improving the quality of patient care. This article examines pharmacist involvement in two drug use protocols in place at St. Luke's Episcopal Hospital in Houston. The first is a pharmacist conversion order protocol in which pharmacists are given the responsibility of flagging and monitoring IV to oral dosage conversions of selected medications; the second is a pharmacist screening program for parenteral ketorolac dosing.
    Hospital formulary 12/1994; 29(11):767-72.